Aquilo Capital Management, LLC has bought stock on 16 days since Aug 2021
10% owner at Spero Therapeutics, Inc., and 1 other company
SEC CIK 0001591986 · Filings on SEC.gov ↗
Aquilo Capital Management, LLC's record
3 months after each buy, from the first price a copier could get.
13 buys since 2021 with 3 months of prices.
Companies
Every filing
23 filings since Jul 2020, newest first
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Spero Therapeutics, Inc.
10% owner
Pieris Pharmaceuticals, Inc.
10% owner
Filings come from SEC EDGAR. Not investment advice.